Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.
Bria E, Di Modugno F, Sperduti I, Iapicca P, Visca P, Alessandrini G, Antoniani B, Pilotto S, Ludovini V, Vannucci J, Bellezza G, Sidoni A, Tortora G, Radisky DC, Crinò L, Cognetti F, Facciolo F, Mottolese M, Milella M, Nisticò P.
Bria E, et al. Among authors: visca p.
Oncotarget. 2014 Nov 30;5(22):11054-63. doi: 10.18632/oncotarget.2609.
Oncotarget. 2014.
PMID: 25373410
Free PMC article.